*Cancer Research Center, Department of Otolaryngology, Head and Neck Surgery, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, Iran **Department of Otolaryngology, Head and Neck Surgery, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, Iran ***Department of Surgery, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran ****Department of Radiation O...

Institutions: Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Department of Anatomic Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Laboratory of Hospital Pharmacy, Nagoya City University Graduate School of Pharmaceutical Sciences,Department of Tumor Immunology, Aichi Medical University School of ...

1Department of Clinical Oncology, University Hospital in Krakow, Krakow, Poland 2Department of Experimental and Clinical Surgery, Jagiellonian University Medical College, Krakow, Poland 3Department of Palliative Medicine, Department of Internal Medicine and Geriatrics, University Hospital in Krakow, Krakow, Poland 4Department of Pain Treatment and Palliative Care, Jagiellonian University Medica...

1 HanseMerkur Center for Traditional Chinese Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany 2Department of Clinical Oncology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea 3 Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, StaudingerWeg 5, 55128 Mainz, Germany 4Departm...

Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands: EG, CL, CT, KS, JAR, GJP; Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of Pisa; Italy: EG, SN, SR, RD; Medical Oncology Branch, National Cancer Institute, Bethesda, MD, US: GG Molecular Pharmacology Fast Forward. Published on January 10, 2008 as doi:10.1124/mol.107...

K. Fizazi1, F. A. Greco2, N. Pavlidis3, G. Daugaard4, K. Oien5 & G. Pentheroudakis3, on behalf of the ESMO Guidelines Committee* Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Tennessee Oncology, Centennial Medical Center, Nashville, USA; Department of Medical Oncology, University of Ioannina, Ioannina, Greece; Department of Oncology 5073, Ri...

1Department of Pediatric Oncology/Hematology, Erasmus Medical Center–Sophia Children’s Hospital, Rotterdam, The Netherlands; 2Molecular Haematology and Cancer Biology Unit, Institute of Child Health and Great Ormond Street Hospital for Children, University College London, London, United Kingdom; 3Department of Clinical Medicine, Prevention and Biotechnologies, Section of Medical Statistics, Uni...

E. KILSDONK, E. van DULMEN-DEN BROEDER, L.C. KREMER, M.M. van den HEUVEL-EIBRINK, F.E. Van LEEUWEN, M.H. van den BERG, M.W. JASPERS a Department of Medical Informatics, Academic Medical Center, the Netherlands b Department of Pediatrics, VU Medical Center, the Netherlands c Department of Pediatric Oncology, Academic Medical Center, the Netherlands d Department of Pediatric Oncology, Erasmus Med...

1Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA 2Department of Radiation Oncology, Sandra and Malcolm Berman Cancer Institute, Greater Baltimore Medical Center, Baltimore, Maryland, USA 3Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 4Department of Medical Oncology, Sandra and Malcolm Berman Cancer Institu...